Scaling up, staying agile: a microbiology lab’s journey from ad hoc projects to routine workflows
:quality(80))
Join us for an insightful webinar with Dr Alban Ramette (University of Bern, Switzerland), exploring how his lab scaled its nanopore sequencing from a single MinION to a high-throughput, flexible operation spanning a range of microbiology applications.
Dr. Ramette will share his team’s experience validating an amplicon sequencing workflow for routine use, integrating metagenomics into everyday practice, and evaluating microbial isolate sequencing as a complementary approach. He will also explain how the lab accommodates urgent samples and ad hoc projects alongside established workflows, without interrupting sequencing runs already in progress.
The session will be followed by a live Q&A with Dr Ramette.
In this webinar, you will learn:
- What prompted the lab to adopt nanopore sequencing
- Why they progressed from MinION as demand grew
- How an amplicon workflow was validated for routine use
- How metagenomics is applied routinely
- Why microbial isolate sequencing is being evaluated as a complementary approach
- How validated workflows and ad hoc projects run simultaneously without interrupting sequencing
Meet the speakers
:quality(80))
Alban Ramette , Head of the Bioinformatics & Biostatistics Group at the Institute for Infectious Diseases (IFIK), University of BernProf. Dr Alban Ramette is the Head of the Bioinformatics & Biostatistics Group at the Institute for Infectious Diseases (IFIK), University of Bern, Switzerland. A pioneer in clinical third-generation genomics, he established the world’s first ISO/IEC 17025-accredited laboratory workflow for bacterial Oxford Nanopore sequencing in 2019. He oversees the university's Certified Nanopore Service Provider platform, specializing in long-read metagenomics, WGS, amplicon profiling, and the development of robust bioinformatic pipelines for rapid clinical microbial diagnostics and surveillance.
:quality(80))
Scott Markland, Senior Product Marketing Manager — MinION and GridION, Oxford Nanopore TechnologiesScott Markland is a product marketing and commercial strategy professional with over 14 years of experience in biotechnology, molecular diagnostics, and genomics. He has a proven track record of bringing innovative technologies to market, leading global product launches, product strategy, and customer engagement. Having progressed from laboratory R&D to a variety of commercial roles, Scott combines deep scientific expertise with strategic marketing to accelerate the adoption of transformative technologies and improve outcomes for scientists across a wide variety of disciplines.
